[Diagnostic and treatment pitfalls and guidelines for variants of squamous cell carcinomas of the head and neck: on behalf of the REFCOR].

Variants des carcinomes épidermoïdes dans les voies aérodigestives supérieures (VADS), implications pour le diagnostic et la prise en charge, selon les référentiels du REFCOR.
Acantholytic Acantholytique/adénoïde Adenoid carcinoma Adenosquamous Adénosquameux Basaloid Basaloïde Cancer/carcinome HNSCC Head and neck cancer Lymphoepithelial Lymphoépithélial Papillaire Papillary Sarcomatoid Spindle cell Squamous cell carcinoma Variant Verrucous Verruqueux Voies aérodigestives supérieures À cellules fusiformes/sarcomatoïde Épidermoïde

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 07 12 2018
accepted: 19 01 2019
pubmed: 18 3 2019
medline: 19 4 2019
entrez: 18 3 2019
Statut: ppublish

Résumé

Among the 20,000 new cases of head and neck neoplasms in France each year, squamous cell carcinomas (HNSCC) represent about 90 % of the cases. Among these, variants of conventional squamous cell carcinomas represent between 5% and 10% of cases. Patient history and risk factors are often similar from those of conventional HSNCC. Variants may, however, be misdiagnosed, which can lead to therapeutic mismanagement due to confusion with sarcomas, glandular tumors or even benign tumors. Diagnostic workup needs to be more cautionary or to include additional exams not to omit their most aggressive component in the case of composite tumors or to under stage the tumor. Immunohistochemistry and specific molecular analyses may be required for proper diagnosis. Central pathological review may also be essential for some of these variants. In addition, some variants are radioresistant and, conversely, others are radiosensitive. An update of the REFCOR 2008 standards was carried out in the light of the international literature and the 2017 WHO/IARC classification for the seven main variants of HNSCC, verrucous, acantholytic (to be named adenoid carcinomas), basaloid, papillary, spindle cell (incorrectly named sarcomatoid), adenosquamous and lymphoepithelial carcinomas.

Identifiants

pubmed: 30878134
pii: S0007-4551(19)30113-4
doi: 10.1016/j.bulcan.2019.01.015
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

395-403

Informations de copyright

Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Juliette Thariat (J)

Centre François-Baclesse/Archade, département de radiothérapie-oncologie, 3, avenue General-Harris, 14000 Caen, France; Laboratoire de physique corpusculaire IN2P3/ENSICAEN - UMR6534, 14000 Caen, France; Unicaen - Normandie université, 14000 Caen, France. Electronic address: jthariat@gmail.com.

Muriel Hourseau (M)

Hôpital Bichat, département d'anatamo-pathologie, 46, rue Henri-Huchard, 75018 Paris, France.

Anne-Catherine Baglin (AC)

AP-HP, université Paris Diderot, hôpital Lariboisière, département d'anatamo-pathologie, 2, rue Ambroise-Paré, 75475 Paris cedex 10, France.

Laurence Digue (L)

Réseau de Cancérologie d'Aquitaine, CHU de Bordeaux, département d'oncologie médicale, 33076 Bordeaux, France.

Noémie Vulquin (N)

Centre Georges-François-Leclerc Center, département de radiothérapie, Dijon, France.

Cécile Badoual (C)

HEGP, department of pathology, 20 rue Leblanc, 75015 Paris, France.

Bertrand Baujat (B)

CHU Tenon, department of head and neck surgery, 4 rue de la Chine, 75020 Paris, France.

Francois Janot (F)

Institute Gustave-Roussy, département de cancérologie cervico-faciale-cancer ORL, 114, rue Edouard-Vaillant, 94800 Villejuif, France.

Francois-Régis Ferrand (FR)

Hôpital Begin, département d'oncologie médicale, 69, avenue de Paris, 94160 Saint-Mandé, France.

Beatrix Barry (B)

Hôpital Bichat, département d'oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale, 46 rue Henri-Huchard, 75018 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH